These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15203110)

  • 1. Identification of heparin affin regulatory peptide domains with potential role on angiogenesis.
    Polykratis A; Delbé J; Courty J; Papadimitriou E; Katsoris P
    Int J Biochem Cell Biol; 2004 Oct; 36(10):1954-66. PubMed ID: 15203110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.
    Héroult M; Bernard-Pierrot I; Delbé J; Hamma-Kourbali Y; Katsoris P; Barritault D; Papadimitriou E; Plouet J; Courty J
    Oncogene; 2004 Mar; 23(9):1745-53. PubMed ID: 15001987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HARP induces angiogenesis in vivo and in vitro: implication of N or C terminal peptides.
    Papadimitriou E; Polykratis A; Courty J; Koolwijk P; Heroult M; Katsoris P
    Biochem Biophys Res Commun; 2001 Mar; 282(1):306-13. PubMed ID: 11264008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial cell proliferation induced by HARP: implication of N or C terminal peptides.
    Papadimitriou E; Heroult M; Courty J; Polykratis A; Stergiou C; Katsoris P
    Biochem Biophys Res Commun; 2000 Jul; 274(1):242-8. PubMed ID: 10903925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosaminoglycans promote HARP/PTN dimerization.
    Bernard-Pierrot I; Héroult M; Lemaître G; Barritault D; Courty J; Milhiet PE
    Biochem Biophys Res Commun; 1999 Dec; 266(2):437-42. PubMed ID: 10600521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of heparin on bovine epithelial lens cell proliferation induced by heparin affin regulatory peptide.
    Delbé J; Vacherot F; Laaroubi K; Barritault D; Courty J
    J Cell Physiol; 1995 Jul; 164(1):47-54. PubMed ID: 7790396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin affin regulatory peptide/pleiotrophin negatively affects diverse biological activities in C6 glioma cells.
    Parthymou A; Lampropoulou E; Mikelis C; Drosou G; Papadimitriou E
    Eur J Cell Biol; 2008 Jan; 87(1):17-29. PubMed ID: 17881084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Implication of HARP in angiogenesis and possible therapeutic role].
    Delbe J; Katsoris P; Milhiet PE; Barritault D; Caruelle D; Courty J
    Pathol Biol (Paris); 1999 Apr; 47(4):352-7. PubMed ID: 10372404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The angiogenic factor heparin affin regulatory peptide (HARP) induces proliferation of human peripheral blood mononuclear cells.
    Achour A; Laaroubi D; Caruelle D; Barritault D; Courty J
    Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL73-7. PubMed ID: 11936877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin affin regulatory peptide modulates the endogenous anticoagulant activity of heparin and heparan sulphate mimetics.
    Mejdoubi-Charef N; Courty J; Sineriz F; Papy-Garcia D; Charef S
    Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):296-302. PubMed ID: 22672269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin affin regulatory peptide is a key player in prostate cancer cell growth and angiogenicity.
    Hatziapostolou M; Delbe J; Katsoris P; Polytarchou C; Courty J; Papadimitriou E
    Prostate; 2005 Oct; 65(2):151-8. PubMed ID: 15924335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the heparin-binding region of snake venom vascular endothelial growth factor (VEGF-F) and its blocking of VEGF-A165.
    Yamazaki Y; Tokunaga Y; Takani K; Morita T
    Biochemistry; 2005 Jun; 44(24):8858-64. PubMed ID: 15952792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of heparin affin regulatory peptide on the expression of vascular endothelial growth factor receptors in endothelial cells.
    Kokolakis G; Mikelis C; Papadimitriou E; Courty J; Karetsou E; Katsoris P
    In Vivo; 2006; 20(5):629-35. PubMed ID: 17091770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of heparin affin regulatory peptide signaling in human endothelial cells.
    Polykratis A; Katsoris P; Courty J; Papadimitriou E
    J Biol Chem; 2005 Jun; 280(23):22454-61. PubMed ID: 15797857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The minimal active domain of endostatin is a heparin-binding motif that mediates inhibition of tumor vascularization.
    Olsson AK; Johansson I; Akerud H; Einarsson B; Christofferson R; Sasaki T; Timpl R; Claesson-Welsh L
    Cancer Res; 2004 Dec; 64(24):9012-7. PubMed ID: 15604266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fucosylated chondroitin sulfate from echinoderm modulates in vitro fibroblast growth factor 2-dependent angiogenesis.
    Tapon-Bretaudière J; Chabut D; Zierer M; Matou S; Helley D; Bros A; Mourão PA; Fischer AM
    Mol Cancer Res; 2002 Dec; 1(2):96-102. PubMed ID: 12496356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferation and migration activities of fibroblast growth factor-2 in endothelial cells are modulated by its direct interaction with heparin affin regulatory peptide.
    Dos Santos C; Blanc C; Elahouel R; Prescott M; Carpentier G; Ori A; Courty J; Hamma-Kourbali Y; Fernig DG; Delbé J
    Biochimie; 2014 Dec; 107 Pt B():350-7. PubMed ID: 25315978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic response of endothelial cells to heparin-binding domain of fibronectin.
    Viji RI; Kumar VB; Kiran MS; Sudhakaran PR
    Int J Biochem Cell Biol; 2008; 40(2):215-26. PubMed ID: 17766169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosaminoglycans differentially bind HARP and modulate its biological activity.
    Vacherot F; Delbé J; Heroult M; Barritault D; Fernig DG; Courty J
    J Biol Chem; 1999 Mar; 274(12):7741-7. PubMed ID: 10075664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the mitogenic, angiogenic and tumorigenic activities of pleiotrophin by a synthetic peptide corresponding to its C-thrombospondin repeat-I domain.
    Hamma-Kourbali Y; Bernard-Pierrot I; Heroult M; Dalle S; Caruelle D; Milhiet PE; Fernig DG; Delbé J; Courty J
    J Cell Physiol; 2008 Jan; 214(1):250-9. PubMed ID: 17607711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.